rs569851088
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_152393.4(KLHL40):c.1850G>A(p.Cys617Tyr) variant causes a missense change. The variant allele was found at a frequency of 0.0000343 in 1,601,210 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. C617R) has been classified as Benign.
Frequency
Consequence
NM_152393.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KLHL40 | NM_152393.4 | c.1850G>A | p.Cys617Tyr | missense_variant | 6/6 | ENST00000287777.5 | NP_689606.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KLHL40 | ENST00000287777.5 | c.1850G>A | p.Cys617Tyr | missense_variant | 6/6 | 1 | NM_152393.4 | ENSP00000287777.4 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152164Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000477 AC: 12AN: 251350Hom.: 0 AF XY: 0.0000663 AC XY: 9AN XY: 135844
GnomAD4 exome AF: 0.0000338 AC: 49AN: 1448928Hom.: 0 Cov.: 27 AF XY: 0.0000346 AC XY: 25AN XY: 721766
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152282Hom.: 0 Cov.: 33 AF XY: 0.0000537 AC XY: 4AN XY: 74466
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 06, 2022 | The c.1850G>A (p.C617Y) alteration is located in exon 6 (coding exon 6) of the KLHL40 gene. This alteration results from a G to A substitution at nucleotide position 1850, causing the cysteine (C) at amino acid position 617 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at